The Signifier And The Signified

Business Wire: Signifier Medical Technologies Secures European Union Medical Device Regulation (EU MDR) Certification for eXciteOSA ®

LONDON--(BUSINESS WIRE)--Signifier Medical Technologies Limited (“Signifier”), a global leader in medical technology for sleep-disordered breathing, announces that it has achieved the EU MDR ...

Signifier Medical Technologies Secures European Union Medical Device Regulation (EU MDR) Certification for eXciteOSA ®

The Signifier And The Signified 3

Business Wire: Signifier Medical Technologies Announces Milestone Order of 10,000 eXciteOSA Devices by Leading Home Medical Equipment Provider, Spectrum Sleep Solutions Inc.

The Signifier And The Signified 4

BOSTON--(BUSINESS WIRE)--Signifier Medical Technologies Limited (“Signifier” and the “Company”), a leader in medical technologies specializing in sleep apnea therapy solutions, is thrilled to announce ...

The Signifier And The Signified 5

Signifier Medical Technologies Announces Milestone Order of 10,000 eXciteOSA Devices by Leading Home Medical Equipment Provider, Spectrum Sleep Solutions Inc.

Play Station Universe: The Signifier: Director’s Cut Enhances The Psychological Thriller With New Content On PS5 And PS4 Later This Year

Raw Fury has announced that The Signifier: Director’s Cut will be coming to PS5 and PS4 later this year, with enhanced features for PS5 and brand new content on both platforms. The ...

The Signifier: Director’s Cut Enhances The Psychological Thriller With New Content On PS5 And PS4 Later This Year

VentureBeat: Signifier Medical Technologies Raises $35M in Series D Funding Round to Accelerate Commercialization of eXciteOSA Therapy

The Signifier And The Signified 10

Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This ...

The Signifier And The Signified 11

Signifier Medical Technologies Raises $35M in Series D Funding Round to Accelerate Commercialization of eXciteOSA Therapy